Sarepta Therapeutics
SRPT
#1483
Rank
โ‚น988.72 B
Marketcap
โ‚น10,368
Share price
-2.15%
Change (1 day)
60.16%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Sarepta Therapeutics (SRPT) - P/B ratio

P/B ratio as of November 2024 : 10.9

According to Sarepta Therapeutics 's latest financial reports the company has a price-to-book ratio of 7.80835.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Sarepta Therapeutics - P/B ratio (from 2001 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-31N/A-100%
2023-12-3110.5-64.47%
2022-12-3129.5249.71%
2021-12-318.45-52.16%
2020-12-3117.748.95%
2019-12-3111.957.82%
2018-12-317.5164.9%
2017-12-314.562.45%
2016-12-314.45-51.91%
2015-12-319.25283.15%
2014-12-312.41-22.41%
2013-12-313.11-52.96%
2012-12-316.61102.84%
2011-12-313.26-103.86%
2010-12-31-84.6-1338.5%
2009-12-316.83129.38%
2008-12-312.98-13.59%
2007-12-313.44-23.19%
2006-12-314.4836.28%
2005-12-313.291.78%
2004-12-313.230.02%
2003-12-313.23-42.85%
2002-12-315.66

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
6.12-43.91%๐Ÿ‡บ๐Ÿ‡ธ USA
-3.51-132.17%๐Ÿ‡บ๐Ÿ‡ธ USA
4.04-62.93%๐Ÿ‡บ๐Ÿ‡ธ USA
-3.60-132.95%๐Ÿ‡บ๐Ÿ‡ธ USA
< -1000-104,665.29%๐Ÿ‡บ๐Ÿ‡ธ USA
-3.16-129.00%๐Ÿ‡บ๐Ÿ‡ธ USA
314 2,779.37%๐Ÿ‡บ๐Ÿ‡ธ USA